Takeda · 7 hours ago
CDMO-CTO Management Strategy and Operations Director
Takeda is a leading global biopharmaceutical company, and they are seeking a CDMO-CTO Management Strategy and Operations Director. This role is responsible for aligning the supply base to PharmSci’s goals, maximizing efficiency and effectiveness through standardized processes, and managing relationships with external suppliers and internal stakeholders.
BiotechnologyHealth CareManufacturingMedicalPharmaceutical
Responsibilities
Support alignment of strategic supplier base with our network strategies, Future Fit, Digital Readiness, and Innovation needs working closely with each PharmSci R&D function (Drug Product & Device Development, Analytical Development, Biologics Process Development, Synthetic Molecules Process Development, and Program Leadership)
Develop and maintain CDMO-CTO Management’s Vendor Network Strategy through continuous governance and evaluation of performance, effectiveness and strategic fit of vendors selected
Continually optimize and socialize CDMO-CTO Relationship Management operating model and standardize our supplier-centric processes to maximize our efficiencies with our engagements with internal stakeholders (PharmSci Technical functions, Legal, Finance, Procurement, and Global Manufacturing Services) and our strategic external suppliers
Create and maintain necessary GXP documentation and trainings on operating model
Support the ongoing management and oversight of existing critical vendors including performance management, KPIs, business/financial risk evaluations, and governance
Represent CDMO Management on strategic initiatives such as clinical manufacturing site selection and capacity planning. Develop strategies to reduce the external manufacturing footprint by 10% year over year
Align the global vendor network strategies across categories, regions and business functions (including but not limited to Global Manufacturing Services, Global Procurement, Global Clinical Supply Chain, Legal)
Develop a framework to capture network vendor performance through fit-for-purpose KPIs, translating to dashboards and operationalize a solution to enable continuous network optimization
Build and manage a strategic road map across People, Process and Systems to standardize work and improve efficiency across CDMO-CTO team and the wider PharmSci teams
Act as business process standardization and optimization SME. This includes manage vendor governance meeting charters, templates and procedures; create, update and maintain procedures and processes for CDMO-CTO Relationship Management; update and socialize CDMO-CTO team operating model; update and optimize Site Selection process, inventory management etc
Help identify, onboard, and then manage the business relationship of our new and existing strategic suppliers in line with functional and network strategies
Establish a strategy to import CDMO data into Takeda’s data fabric to enable aspirational digital innovation
Build / drive an optimal usage of existing system solutions to allow centralized production visibility across the internal and external vendor base, ensure inventory compliance, enable lot genealogy and provide an interface with finance, global clinical supply chain and technical functions
Plan and maintain a rolling annual calendar of vendor governance meetings (Business Review Meetings – BRMS, Joint Steering Committees – JSC etc) with CDMOs, CTOs and Medical Device suppliers and support internal vendor network governance meetings as well as manage engagement at trade shows like DCAT and CHPI
Provide support to Product Operating Model (POM) as required
Create and maintain standardized processes for site selection, vendor performance review and governance to be utilized by CDMO Relationship Managers and socialize within Pharm Sci
Serve on Pharmaceutical Sciences cross-functional workstreams as CDMO Management SME and represent teams responsibilities and strategies
Establish strong relationships with team members and internal stakeholders to facilitate operating model awareness and consistency
Work closely with PharmSci Leads, Analytical development, Device Development Leads, , and other internal business partners (Procurement, Finance, Legal, Global Manufacturing Sciences) to proactively identify program / portfolio risks and develop robust mitigation and contingency plans
Proactively identify, action, or elevate internal and external supplier issues and conflicts in a professional and timely manner
Partner with Takeda stakeholders to select among existing or develop new CDMOs who can meet program requirements and augment Takeda’s internal or external manufacturing network capabilities
Establish clear and consistent supplier governance models to ensure clear lines of communication, meeting cadence, and escalation paths
Establish and support global network / supplier strategies that align with PharmSci R&D function needs and expectations, short and long term strategies
Ability to critically review, process and understand complex business challenges, provide potential solutions
Qualification
Required
Bachelor Degree in Engineering, Biotechnology, Business or scientific field
Minimum of 10-15 years relevant clinical/commercial drug, device, and/or combination product Pharmaceutical experience
Preferred
MBA or Masters Degree
Benefits
Medical, dental, vision insurance
401(k) plan and company match
Short-term and long-term disability coverage
Basic life insurance
Tuition reimbursement program
Paid volunteer time off
Company holidays
Well-being benefits
Up to 80 hours of sick time
Up to 120 hours of paid vacation
Company
Takeda
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.
H1B Sponsorship
Takeda has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (45)
2024 (39)
2023 (38)
2022 (34)
2021 (44)
2020 (18)
Funding
Current Stage
Public CompanyTotal Funding
$2.46B2025-06-27Post Ipo Debt· $2.4B
2016-09-01Grant· $19.8M
2016-05-08Grant· $38M
Leadership Team
Recent News
2026-01-25
legacy.thefly.com
2026-01-23
2026-01-22
Company data provided by crunchbase